npj Vaccines (Apr 2024)

Triple tandem trimer immunogens for HIV-1 and influenza nucleic acid-based vaccines

  • Iván del Moral-Sánchez,
  • Edmund G. Wee,
  • Yuejiao Xian,
  • Wen-Hsin Lee,
  • Joel D. Allen,
  • Alba Torrents de la Peña,
  • Rebeca Fróes Rocha,
  • James Ferguson,
  • André N. León,
  • Sylvie Koekkoek,
  • Edith E. Schermer,
  • Judith A. Burger,
  • Sanjeev Kumar,
  • Robby Zwolsman,
  • Mitch Brinkkemper,
  • Aafke Aartse,
  • Dirk Eggink,
  • Julianna Han,
  • Meng Yuan,
  • Max Crispin,
  • Gabriel Ozorowski,
  • Andrew B. Ward,
  • Ian A. Wilson,
  • Tomáš Hanke,
  • Kwinten Sliepen,
  • Rogier W. Sanders

DOI
https://doi.org/10.1038/s41541-024-00862-8
Journal volume & issue
Vol. 9, no. 1
pp. 1 – 18

Abstract

Read online

Abstract Recombinant native-like HIV-1 envelope glycoprotein (Env) trimers are used in candidate vaccines aimed at inducing broadly neutralizing antibodies. While state-of-the-art SOSIP or single-chain Env designs can be expressed as native-like trimers, undesired monomers, dimers and malformed trimers that elicit non-neutralizing antibodies are also formed, implying that these designs could benefit from further modifications for gene-based vaccination approaches. Here, we describe the triple tandem trimer (TTT) design, in which three Env protomers are genetically linked in a single open reading frame and express as native-like trimers. Viral vectored Env TTT induced similar neutralization titers but with a higher proportion of trimer-specific responses. The TTT design was also applied to generate influenza hemagglutinin (HA) trimers without the need for trimerization domains. Additionally, we used TTT to generate well-folded chimeric Env and HA trimers that harbor protomers from three different strains. In summary, the TTT design is a useful platform for the design of HIV-1 Env and influenza HA immunogens for a multitude of vaccination strategies.